EUCTR2013-004130-15-DE进行中（未招募）1 期
Investigator-initiated clinical research trial on the effects of 5% Minoxidil topical foam on gene expression, hair growth and scalp microenvironment in men with androgenetic alopecia - AGA Array Minoxidil
Charité-Universitätsmedizin Berlin, Department of Dermatology, Clinical Research Center for Hair and Skin Science0 个研究点目标入组 12 人开始时间: 2014年3月5日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Male
入选标准
- •healthy male patients 21 - 45 years of age
- •Exhibits male AGA based on a discernable hair loss in temple and vertex region rating Hamilton-Norwood Scale IIIvertex to IV
- •negative plug test occipital
- •Willing to maintain the same hairstyle, hair length and hair color throughout the study
- •Subjects who are willing and able to comply with scheduled visits, treatment plan, mini-tattoo and other trial procedures
- •Written informed consent of the patients
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 12
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Known to be hypersensitive to minoxidil, hair dye (p-phenylenediamine), tattoo ink, fragrances, hair gel or any vehicle components
- •Current or 4 weeks dated back use of medical shampoos or solutions which include Ketoconazole or the like (e. g. Terzolin®) in the target region interfering with the CTM or examination method
- •Current or 3 months dated back use of topical treatment in the target regions taken for more than 2 consecutive weeks interfering with the CTM (topical corticosteroids, aminexil, minoxidil, estrogens)
- •Current or 3 months dated back use of systemic treatment (drugs or dietary supplement) taken for more than 2 consecutive weeks interfering with the CTM or examination method (beta blocker, cimetidine, diazoxide, isotretionin, corticosteroids, vitamin A intake above 10000 IU per day)
- •Current or 12 months dated back use of Finasteride (Propecia®, FinaHair®, etc.), Dutasteride or a similar product
- •Within past 12 months undergoing chemotherapy or receiving cytotoxic agents as well as radiation and/or laser/surgical therapy of the scalp
- •Current or prior enrollment in any other investigational medication (drug) study within the 4 weeks prior to study initiation.
- •Presence of hair transplants, hair weaves or non-breathable wigs and hair bonding
- •Current or 2 months dated back severe diet or presenting a history of eating disorder
- •Any dermatological disorders of the scalp in the target region with the possibility of interfering with the CTM or examination method, such as fungal or bacterial infections, seborrheic dermatitis, psoriasis, eczema, folliculitis, scars or scalp atrophy
- •Untreated persisting hypertension
- •Active hair loss or history within the past 3 months including diffuse telogen effluvium, alopecia areata, scarring alopecia
- •Other severe, acute or chronic medical condition that may lead to hair loss or interfere with the interpretation of trial results (e. g. untreated hypothyroidism)
- •Persons who are institutionalized because of legal or regulatory order.
研究者
相似试验
招募中
Unknown
Investigator-initiated clinical trial of bradycardia with transvenous vagus nerve stimulation catheters for supraventricular tachyarrhythmiasAtrial fibrillation/Atrial flutter/Atrial tachycardia etc.JPRN-jRCT2072230062Sakamoto Kazuo20
招募中
2 期
AllinOne-K-2JPRN-jRCT1080224639Takuya Takahashi10
已完成
不适用
An investigator-initiated clinical research on the ability of an electroencephalogram analysis program to differentiate between dementia with Lewy bodies (DLB) and Alzheimer's disease (AD)JPRN-UMIN000035926Department of Behavioral Neurology and Neuropsychiatry, Osaka University United Graduate School of Child Development40
进行中（未招募）
1 期
Investigator-initiated Clinical Trial to Evaluate the Safety and Efficacy of AX-1911, Magnetic Field Generator for Magnetic Targeting, in Knee OsteoarthritisKnee OsteoarthritisJPRN-jRCT2062210039Kamei Naosuke5
招募中
3 期
Omegaven investigator-initiated trialJPRN-jRCT2021230032Wada Motoshi20